| High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia | |
| Du, Wen; He, Jing; Zhou, Wei; Shu, Simin; Li, Juan; Liu, Wei; Deng, Yun; Lu, Cong; Lin, Shengyan; Ma, Yaokun | |
| 刊名 | JOURNAL OF TRANSLATIONAL MEDICINE
 |
| 2019 | |
| 卷号 | 17 |
| 关键词 | Acute myeloid leukemia Prognosis IL2RA mRNA expression Core binding factor AML Intermediate-risk AML NanoString |
| ISSN号 | 1479-5876 |
| DOI | 10.1186/s12967-019-1926-z |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4215693 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Du, Wen,He, Jing,Zhou, Wei,et al. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia[J]. JOURNAL OF TRANSLATIONAL MEDICINE,2019,17. |
| APA | Du, Wen.,He, Jing.,Zhou, Wei.,Shu, Simin.,Li, Juan.,...&Hu, Dong.(2019).High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.JOURNAL OF TRANSLATIONAL MEDICINE,17. |
| MLA | Du, Wen,et al."High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia".JOURNAL OF TRANSLATIONAL MEDICINE 17(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论